The aim of this study was to measure post-vaccination anti-SARS-CoV-2 antibody levels using an ELISA which detects combined IgG, IgA and IgM (IgGAM) antibodies, not IgG alone, in patients with SLE compared to healthy controls. This evidence concerns the gene CD79A and systemic lupus erythematosus.